Software AG

  • WKN: A2GS40
  • ISIN: DE000A2GS401
  • Land: Germany

Nachricht vom 31.01.2018 | 22:14

Software AG: Sanjay Brahmawar appointed as new CEO for a term of five years effective August 1, 2018

Software AG / Key word(s): Change of Personnel
Software AG: Sanjay Brahmawar appointed as new CEO for a term of five years effective August 1, 2018

31-Jan-2018 / 22:14 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad hoc Disclosure (Inside Information according to Article 17 MAR)

Supervisory Board of Software AG appoints Sanjay Brahmawar as new CEO with effect of August 1, 2018

- Sanjay Brahmawar appointed as new CEO for a term of five years effective August 1, 2018

The Supervisory Board of Software Aktiengesellschaft (TecDAX, ISIN DE000A2GS401, WKN A2GS40, SOW) decided today to appoint Mr. Sanjay Brahmawar as new CEO of Software AG for a five year term with effect of August 1, 2018. Mr. Brahmawar will succeed Mr. Karl-Heinz Streibich, whose term will end on July 31, 2018 as he has reached the recommended age limit.

Software AG

Supervisory Board



Person making the notification:
Frederic Freichel
Junior Manager Investor Relations

Email: frederic.freichel@softwareag.com
Tel: +49 6151 92 1106

31-Jan-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021